SCHEMBL7716622

SCHEMBL7716622

OC1CCN(c2nc(Cl)ncc2Cc2ccccc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.43
▸ MAOB P27338 2/20 0.42
▸ HTR6 P50406 2/20 0.42
▸ PIK3CA P42336 1/20 0.39
▸ SMO Q99835 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ AURKA O14965 2/20 0.39
▸ CDC7 O00311 1/20 0.39
▸ PLK4 O00444 1/20 0.39
▸ CHEK1 O14757 1/20 0.39
▸ PDPK1 O15530 1/20 0.39
▸ JAK2 O60674 1/20 0.39
▸ ROCK2 O75116 1/20 0.39
▸ PAK4 O96013 1/20 0.39
▸ CHEK2 O96017 1/20 0.39
▸ EGFR P00533 1/20 0.39
▸ NTRK1 P04629 1/20 0.39
▸ PRKCG P05129 1/20 0.39
▸ INSR P06213 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714574 0.85 DHFR (0.41) AURKACDC7PLK4CHEK1PDPK1
SCHEMBL7708466 0.82 SMN1; SMN2 (0.55) MAPTHTR6HRH4
SCHEMBL7712401 0.82 HPGD (0.50) MAPTPIK3CAMAPK1HRH3
SCHEMBL7712353 0.78 RPS6KB1 (0.41) HTR6RPS6KB1MAPK12PTPN11
SCHEMBL7716662 0.74 DCLK1 (0.45) MAPTPIK3CAAURKALCKFGFR1
SCHEMBL7714521 0.74 SMO (0.46) MAPTHTR6PIK3CASMOEGFR
SCHEMBL7714288 0.73 DHFR (0.39) —
SCHEMBL1400767 0.73 HCRTR2 (0.47) MAPTPIK3CASMOPIM1STK3
SCHEMBL13649032 0.73 ABL1 (0.56) MAPK1
SCHEMBL7708590 0.71 MAPT (0.47) MAPTRAB9AMAPK1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 — — US disclosed
Send feedback